-+ 0.00%
-+ 0.00%
-+ 0.00%

UROGEN PHARMA - INCREASES 2026 OPERATING EXPENSES GUIDANCE TO $260 MLN-$270 MLN INCLUDING $20 MLN-$24 MLN SHARE-BASED COMP

路透·08/05/2026 12:00:03

登录查看新闻详情